The growing global geriatric population and the rising incidence and prevalence of T2 diabetes are significant factors expected to drive the growth of the diabetes drugs market, not only in mature markets but also in fast-growing countries.
Capitalizing on our unique expertise in the diabetes market and in patient chart-based research, we have designed T2DsyndiTrackTM, our syndicated study, with input from our clients, based on real-world data to monitor the evolution of T2 Diabetes management in some of the most dynamic markets.Example of recent release:
- Latest data from January 2021
- CN, VN, TR, EG, PH, RU, IT, BR
- 663 Diabetologists, Endos, GPs and IMs
- 4,634 real world patient charts
More information about our T2D syndicated study?
- Types of data collected
- Dates of research waves
Fill in the form and we will be in touch shortly. 👉